Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

A groundbreaking treatment for substance use disorder is changing lives by using neuro-stimulation, and it’s exclusively available in the Louisville area.

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

During the COVID-19 pandemic, when fentanyl overdoses surged, doctors were desperate to find ways of helping their patients.

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Pat George, chairman of the Kansas Fights Addiction Act Grant Review Board, gives an update to the Senate Ways and Means ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes ...

Whatcom County Health and Community Services has partnered with the Swinomish tribe’s didgʷálič Wellness Center to bring a ...

Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, ...

The latest health briefs reveal Novo Nordisk's promising obesity treatment and a $7.4 billion Purdue Pharma settlement over ...